Climb Bio, Inc. Common Stock (CLYM)
Across 17 earnings reports since Sep 13, 2021, Climb Bio, Inc. Common Stock (CLYM) has a clear post-earnings pattern. It moves ±4.07% on average after reporting and finishes higher 52.9% of the time. Its largest post-earnings gain was +6.86% (Nov 08, 2021) and its largest decline was -24.92% (May 16, 2022). The next earnings report is predicted for 2026-08-13 (approximate).
Earnings reactions
How CLYM moved on each past earnings report.
Earnings Impact
Total Earnings
17
Avg Abs. Movement
±4.07%
Positive %
52.9%
Negative %
47.1%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| May 07, 2026 | ☀ PRE | -2.45% | open_in_new |
| Mar 05, 2026 | ☀ PRE | +1.37% | open_in_new |
| Nov 06, 2025 | ☀ PRE | +1.57% | open_in_new |
| Aug 12, 2025 | ☀ PRE | -2.13% | open_in_new |
Earnings Count
17
Total earnings in dataset
Avg Abs. Movement
±4.07%
Avg % price change on earnings
Institutional ownership
Holdings as of Mar 31, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| SCHEDULE 13G | 20260708 | open_in_new SEC.gov |
| SCHEDULE 13D/A | 20260707 | open_in_new SEC.gov |
| 3 | 20260701 | open_in_new SEC.gov |
| 4 | 20260701 | open_in_new SEC.gov |
| 4 | 20260701 | open_in_new SEC.gov |
| 8-K | 20260701 | open_in_new SEC.gov |
| 144 | 20260630 | open_in_new SEC.gov |
| 4 | 20260630 | open_in_new SEC.gov |
| 424B5 | 20260612 | open_in_new SEC.gov |
| 8-K | 20260612 | open_in_new SEC.gov |
Frequently asked about CLYM earnings
When does Climb Bio, Inc. Common Stock report earnings next? expand_more
Climb Bio, Inc. Common Stock (CLYM)'s next earnings date is approximate for 2026-08-13. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does CLYM stock move after earnings? expand_more
Over 17 reports, CLYM has moved an average of ±4.07% the session after earnings, closing higher 52.9% of the time.
What was CLYM's biggest post-earnings move? expand_more
CLYM's largest post-earnings gain on record was +6.86% on Nov 08, 2021, and its largest decline was -24.92% on May 16, 2022.
Where can I find Climb Bio, Inc. Common Stock's SEC filings? expand_more
All of Climb Bio, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right